Global estimates of cancer prevalence for 27 sites in the adult population in 2008
Reads0
Chats0
TLDR
The latest estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008 and highlight the need for long‐term care targeted at managing patients with certain very frequently diagnosed cancer forms.Abstract:
Recent estimates of global cancer incidence and survival were used to update previous figures of limited duration prevalence to the year 2008. The number of patients with cancer diagnosed between 2004 and 2008 who were still alive at the end of 2008 in the adult population is described by world region, country and the human development index. The 5-year global cancer prevalence is estimated to be 28.8 million in 2008. Close to half of the prevalence burden is in areas of very high human development that comprise only one-sixth of the world's population. Breast cancer continues to be the most prevalent cancer in the vast majority of countries globally; cervix cancer is the most prevalent cancer in much of Sub-Saharan Africa and Southern Asia and prostate cancer dominates in North America, Oceania and Northern and Western Europe. Stomach cancer is the most prevalent cancer in Eastern Asia (including China); oral cancer ranks as the most prevalent cancer in Indian men and Kaposi sarcoma has the highest 5-year prevalence among men in 11 countries in Sub-Saharan Africa. The methods used to estimate point prevalence appears to give reasonable results at the global level. The figures highlight the need for long-term care targeted at managing patients with certain very frequently diagnosed cancer forms. To be of greater relevance to cancer planning, the estimation of other time-based measures of global prevalence is warranted.read more
Citations
More filters
Journal ArticleDOI
CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.
Ana Isabel Fraguas-Sánchez,Ana Fernández-Carballido,R. Simancas-Herbada,Cristina Martín-Sabroso,Ana Isabel Torres-Suárez +4 more
TL;DR: The promising inclusion of CBD in conventional breast cancer chemotherapy and the use of CBD-Mps for the extended release of this cannabinoid, optimising the effect of the chemotherapeutic agents are evidences.
Journal ArticleDOI
Impact of Bone-targeted Therapies in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients Treated with Abiraterone Acetate: Post Hoc Analysis of Study COU-AA-302
Fred Saad,Neal D. Shore,Hendrik Van Poppel,Dana E. Rathkopf,Matthew R. Smith,Johann S. de Bono,Christopher J. Logothetis,Paul de Souza,Karim Fizazi,Peter F.A. Mulders,Paul N. Mainwaring,John D. Hainsworth,Tomasz M. Beer,Scott North,Yves Fradet,Thomas A. Griffin,Peter De Porre,Anil Londhe,Thian Kheoh,Eric J. Small,Howard I. Scher,Arturo Molina,Charles J. Ryan +22 more
TL;DR: This post hoc analysis showed that in patients with advanced prostate cancer who were treated with abiraterone acetate and prednisone in combination with bone-targeted therapy, there was a continued trend in prolongation of life when compared with patients treated withprednisone alone.
Journal ArticleDOI
Implementation of cervical cancer screening and prevention in China—challenges and reality
Shaoming Wang,You-Lin Qiao +1 more
TL;DR: Challenges confronted in the prevention and control of cervical cancer in China are reviewed to appeal for future multi-collaborations and potential solutions to acquire the final success of the campaign.
Journal ArticleDOI
Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.
Ramón García-Escudero,Carmen Segrelles,Marta Dueñas,María Pombo,Claudio Ballestín,Marina Alonso-Riaño,Pablo Nenclares,Roberto Álvarez-Rodríguez,Gregorio Sánchez-Aniceto,Ana Maria Ruiz-Alonso,José Luis López-Cedrún,Jesús M. Paramio,Corina Lorz +12 more
TL;DR: High expression of PIK3CA in HNSCC primary tumors identifies patients at high risk for recurrence, and the activation of the Hippo-YAP pathway could underlie tumor progression in PI3KCA overexpressing tumors.
Journal ArticleDOI
Awareness of breast cancer and breast self-examination among female undergraduate students in a higher teachers training college in Cameroon.
Carlson-Babila Sama,Bonaventure Suiru Dzekem,Jules Kehbila,Cyril Jabea Ekabe,Brice Nguedia Vofo,Naomi Liteba Abua,Therence Nwana Dingana,Fru Angwafo +7 more
TL;DR: Though most students are aware of the existence of breast cancer, their overall knowledge on its risk factors and clinical presentation is insufficient with a concomitant low practice of BSE, which warrants intensification of sensitization campaigns and educational programmes.
References
More filters
Journal ArticleDOI
Global cancer statistics
TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Global cancer statistics, 2002.
TL;DR: There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Journal ArticleDOI
Projections of the Cost of Cancer Care in the United States: 2010–2020
TL;DR: The national cost of cancer care is substantial and expected to increase because of population changes alone, and the total cost in 2020 is projected to be $173 billion, which represents a 39% increase from 2010.
Journal ArticleDOI
Cancer burden in the year 2000. The global picture.
TL;DR: Three elementary measures of cancer frequency are confined ourselves to: incidence, mortality and prevalence.